HLscience Co. Ltd (239610) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, HLscience Co. Ltd (239610) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.01 Billion ≈ $-1.36 Million USD) by net assets (₩87.36 Billion ≈ $59.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 239610 market cap overview for the company's overall valuation and market capitalisation.

HLscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how HLscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HLscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLscience Co. Ltd ranked by their cash flow conversion efficiency. Explore 239610 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Fidelity Special Values LSE:FSV	0.010x
FUTURE GAMING GRP INTL AB F:6L50	0.014x
IXUP Ltd AU:IXU	-0.742x
Agung Semesta Sejahtera Tbk PT JK:TARA	-0.005x
GUH Holdings Bhd KLSE:3247	-0.035x
DAIHAN Scientific Co. Ltd KQ:131220	0.006x
SAMJIN Co. Ltd KQ:032750	0.041x
Matichon Public Company Limited BK:MATI	-0.002x

Annual Cash Flow Conversion Efficiency for HLscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of HLscience Co. Ltd from 2014 to 2024. View HLscience Co. Ltd (239610) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩94.54 Billion ≈ $64.07 Million	₩-3.59 Billion ≈ $-2.43 Million	-0.038x	-99.23%
2023-12-31	₩102.59 Billion ≈ $69.53 Million	₩-1.96 Billion ≈ $-1.33 Million	-0.019x	-150.22%
2022-12-31	₩104.22 Billion ≈ $70.63 Million	₩3.95 Billion ≈ $2.68 Million	0.038x	-61.45%
2021-12-31	₩107.26 Billion ≈ $72.69 Million	₩10.56 Billion ≈ $7.16 Million	0.098x	-36.97%
2020-12-31	₩95.84 Billion ≈ $64.95 Million	₩14.97 Billion ≈ $10.14 Million	0.156x	-40.67%
2019-12-31	₩81.21 Billion ≈ $55.04 Million	₩21.38 Billion ≈ $14.49 Million	0.263x	+27.35%
2018-12-31	₩62.99 Billion ≈ $42.69 Million	₩13.02 Billion ≈ $8.82 Million	0.207x	+88.26%
2017-12-31	₩53.14 Billion ≈ $36.01 Million	₩5.83 Billion ≈ $3.95 Million	0.110x	-0.29%
2016-12-31	₩50.19 Billion ≈ $34.01 Million	₩5.53 Billion ≈ $3.75 Million	0.110x	-48.47%
2015-12-31	₩14.53 Billion ≈ $9.85 Million	₩3.10 Billion ≈ $2.10 Million	0.214x	-5.19%
2014-12-31	₩10.26 Billion ≈ $6.95 Million	₩2.31 Billion ≈ $1.57 Million	0.225x	--

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$18.26 Million

₩26.94 Billion KRW

Market Cap Rank

#25488 Global

#1887 in Korea

Share Price

₩5290.00

Change (1 day)

-0.38%

52-Week Range

₩5090.00 - ₩11280.00

All Time High

₩105342.87